One in six Australian pharmacists are pro-life and oppose elective termination of pregnancy. But this does not diminish their responsibilities to patients. Marie enters your...

All the new initiatives, funding schemes and Pharmaceutical Benefits Scheme (PBS) listings that kicked into gear on 1 July 2023.

Neuropathic pain is associated with disability, reduced quality of life and employment, and increased healthcare costs. The prevalence of neuropathic pain in the general...

From 1 November 2023, millions of Australians at risk of severe complications from shingles can receive a Shingrix vaccine under the NIP.

On 1 October 2025, the TGA scheduled methenamine hippurate as a Pharmacist Only medicine to ensure pharmacist oversight of its use.

The TGA has worked with Phenergan manufacturer Sanofi to develop a new contraindication for the medicine in children under 6.